2024年　後期

HOME » 発表論文 » 2024年　後期
  1. Kogawa K, Ito R, Hirano D, Hoshino K. Efficacy & safety of the adenosine administration test in the management of Wolff-Parkinson-White pattern in children with delta waves. Cardiol Young. [Epub ahead of print]. DOI: 10.1017/S104795112403659X.
  2. Nishida H, Imagawa E, Tsunogai T, Saijo N, Ogata J, Sakurai K, Oishi K. A Case of Wiedemann-Steiner Syndrome Caused by a Novel KMT2A c.8862del Variant. Ped Int. [Epub ahead of print]
  3. Sakaguchi H, Hirano D, Kawakami Y, Tokunaga A, Nishizaki N, Endo A, Miyano H, Yuza Y, Hatanaka S, Sasaki T, Kanzaki G, Tsuboi N, Oishi K. Estimating Number of Nephrons in Living Pediatric Patients Using Nephrectomy Specimens. Kidney Int Rep. [Epub ahead of print]. DOI: 10.1016/j.ekir.2024.12.027.
  4. Hirano D, Fujimaru T, Sako M, Tanaka S, Inaba A, Uchimura T, Kamei K, Kubota T, Ohta T, Okamoto T, Tanaka H, Hamada R, Ito S. Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome. Nephrol Dial Transplant. [Epub ahead of print]. DOI: 10.1093/ndt/gfae228.
  5. Sato Y, Hanawa Y, Tsubota A. CRISPR/Cas9-mediated RELA & RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function. Clinical immunology communications. [Epub ahead of print]. DOI: 10.1016/j.clicom.2024.10.002.
  6. Hanawa Y, Namba H. Metacarpophalangeal joint arthritis in IgA vasculitis. Oxf Med Case Reports. 2024; 12: omae157. DOI: 10.1093/omcr/omae157.
  7. Takeuchi H, Kikuchi K, Takeda R, Hirata Y, Matsuura R, Koichihara R, Hamano S. Quantitative analysis of 123I-iomazenil single-photon emission computed tomography findings from patients with infantile epileptic spasm syndrome. Brain Dev. 2024; 47: 104314. DOI: 10.1016/j.braindev.2024.104314.
  8. Matsuoka R, Nonaka E, Fujita S, Akiyama N. Efficacy of the Triple-Dose Prophylactic Vitamin K  Regimen in Healthy Neonates ＆ evaluation of the Utility of Vitamin K Deficiency Screening. Cureus. 2024; 16(11) : e74436. DOI: 10.7759/cureus.74436.
  9. Takeuchi H, Kikuchi K, Takeda R, Hirata Y, Matsuura R, Koichihara R, Oba D, Ohashi H, Hamano S. Effectiveness of vigabatrin for infantile epileptic spasm syndrome categorized by etiologies. Seizure. 2024; 122: 113-118. DOI: 10.1016/j.seizure.2024.10.003.
  10. Matsuura R, Hamano SI, Takeuchi H, Takeda R, Horita H, Hirata Y, Koichihara R, Kikuchi K, Oka A. Adrenocorticotropic hormone therapy alters Q-albumin ratios in patients with infantile epileptic spasms syndrome of unknown etiology. J Neurol Sci. 2024; 465: 123187. DOI: 10.1016/j.jns.2024.123187.
  11. Matsuura R, Hamano SI, Koichihara R, Takeda R, Takeuchi H, Hirata Y, Kikuchi K, Oka A. Serum matrix metallopeptidase-9 levels in infantile epileptic spasms syndrome of unknown etiology. Epilepsy Res 2024; 207: 107454 DOI: 10.1016/j.eplepsyres.2024.107454.
  12. 竹内 博一, 松浦 隆樹, 菊池健二郎, 竹田里可子, 平田 佑子, 小一原 玲子, 浜野 晋一郎. 小児重症筋無力症に対する急性期における免疫グロブリン静注療法の有効性について. 脳と発達. 2024; 56: 119-124.
  13. Takeuchi H, Higurashi N, Toga Y. Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy. Brain Dev. Brain Dev. 2024; 46(6): 219-223. DOI: 10.1016/j.braindev.2024.03.004.